2015
The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis
Danve A, O'Dell J. The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis. International Journal Of Rheumatic Diseases 2015, 18: 714-724. PMID: 26177990, DOI: 10.1111/1756-185x.12713.Peer-Reviewed Original ResearchConceptsGiant cell arteritisPositron emission tomography scanningFDG-PETSystemic vasculitisTakayasu arteritisMagnetic resonance imagingEarly diagnosisFluorodeoxyglucose positron emission tomography scanningCranial giant cell arteritisTomography scanningBlood vesselsInvolved blood vesselsEnd-organ damageLarge vessel vasculitidesPrimary systemic vasculitisSmall vessel vasculitisNon-specific symptomsActive inflammatory cellsStandard imaging testPrediction of relapseDisease activityActive inflammationCell arteritisVessel vasculitisOrgan damage
2012
Thoroughness of Mediastinal Staging in Stage IIIA Non-small Cell Lung Cancer
Vest MT, Tanoue L, Soulos PR, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Thoroughness of Mediastinal Staging in Stage IIIA Non-small Cell Lung Cancer. Journal Of Thoracic Oncology 2012, 7: 188-195. PMID: 22134069, PMCID: PMC3253367, DOI: 10.1097/jto.0b013e318236ecbb.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBiopsy, NeedleCarcinoma, Non-Small-Cell LungCohort StudiesComorbidityConfidence IntervalsGuideline AdherenceHumansLung NeoplasmsLymph NodesMediastinoscopyMediastinumMedicareMultivariate AnalysisNeoplasm StagingOdds RatioPositron-Emission TomographySEER ProgramSurvival AnalysisUnited StatesConceptsStage IIIA non-small cell lung cancerIIIA non-small cell lung cancerNon-small cell lung cancerInvasive stagingCell lung cancerMediastinal stagingLung cancerClinical stage IIIA non-small cell lung cancerEnd Results-Medicare databaseStage IIIA NSCLC patientsPositron emission tomography scanningPathologic lymph nodesIIIA NSCLC patientsMultivariable logistic regressionInvasive mediastinal stagingNSCLC patientsOlder patientsPatient characteristicsLymph nodesPatient factorsHistologic confirmationPractice patternsMedicare claimsMedicare beneficiariesPET scanning
2010
Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder
Murrough JW, Henry S, Hu J, Gallezot JD, Planeta-Wilson B, Neumaier JF, Neumeister A. Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology 2010, 213: 547-553. PMID: 20480149, PMCID: PMC3139174, DOI: 10.1007/s00213-010-1881-0.Peer-Reviewed Original ResearchConceptsMajor depressive disorderMajor depressive episodeDepressive disorderPositron emission tomography scanningCurrent major depressive episodeHealthy control groupSpecific receptor subtypesHealthy control participantsHeteroreceptor functionMethodsTen participantsSerotonin1B receptorsAntidepressant actionΓ-amino butyric acidDepressive episodeGlutamate systemReceptor subtypesVentral pallidumNucleus accumbensDepressive phenotypeReceptor radioligandTherapeutic rationaleMDD groupControl groupDysfunctional rewardTomography scanning
2009
5-HT1A receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-11C]WAY-100635
Sargent PA, Rabiner EA, Bhagwagar Z, Clark L, Cowen P, Goodwin GM, Grasby PM. 5-HT1A receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-11C]WAY-100635. Journal Of Affective Disorders 2009, 123: 77-80. PMID: 19726088, DOI: 10.1016/j.jad.2009.07.015.Peer-Reviewed Original ResearchConceptsEuthymic bipolar patientsBipolar patientsDepressed patientsHealthy controlsReceptor bindingHealthy volunteersPositron emission tomography scanningBipolar depressed patientsUnipolar depressed patientsPositron emission tomographyPercent confidence intervalsBrain 5Drug treatmentNumber of subjectsPatientsReceptor radioligandTomography scanningEmission tomographyConfidence intervalsReceptorsSignificant differencesDepressed stateVolunteersPrevious findingsSubjects
2007
Noninvasive Staging of Non-small Cell Lung Cancer ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive Staging of Non-small Cell Lung Cancer ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition). CHEST Journal 2007, 132: 178s-201s. PMID: 17873168, DOI: 10.1378/chest.07-1360.Peer-Reviewed Original ResearchConceptsChest CT scanningPET scanningCT scanningMediastinal metastasesMetastatic diseaseStaging studiesLung cancerPractice guidelinesLung Cancer ACCP Evidence-Based Clinical Practice GuidelinesACCP Evidence-Based Clinical Practice GuidelinesEvidence-based clinical practice guidelinesMediastinal lymph node metastasisPositron emission tomography scanningTest characteristicsLung cancer guidelinesDistant metastatic diseaseLymph node metastasisClinical practice guidelinesMalignant lymph nodesNoninvasive imaging studiesAbnormal findingsCancer guidelinesLymph nodesNode metastasisAccurate stagingInvasive Mediastinal Staging of Lung Cancer ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive Mediastinal Staging of Lung Cancer ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). CHEST Journal 2007, 132: 202s-220s. PMID: 17873169, DOI: 10.1378/chest.07-1362.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerLymph nodesInvasive stagingMediastinal nodesClinical stage I non-small cell lung cancerLung Cancer ACCP Evidence-Based Clinical Practice GuidelinesACCP Evidence-Based Clinical Practice GuidelinesStage I non-small cell lung cancerNeedle techniqueEvidence-based clinical practice guidelinesLeft upper lobe tumorsNormal-sized lymph nodesPositron emission tomography scanningPET scan findingsUpper lobe tumorsMediastinal lymph nodesCell lung cancerClinical practice guidelinesStaging of patientsInvasive mediastinal stagingHigher FN rateInvasive confirmationMediastinal infiltrationNode enlargementScan findings
2003
The Noninvasive Staging of Non-small Cell Lung Cancer* The Guidelines
Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The Noninvasive Staging of Non-small Cell Lung Cancer* The Guidelines. CHEST Journal 2003, 123: 147s-156s. PMID: 12527574, DOI: 10.1378/chest.123.1_suppl.147s.Peer-Reviewed Original ResearchConceptsChest CT scanningMetastatic diseaseLung cancerCT scanningPhysical examinationClinical evaluationCT scanPET scansWhole body positron emission tomography scanningNon-small cell lung cancerImaging studiesPositron emission tomography scanningAbnormal scan findingsAbdominal CT scanCell lung cancerMalignant lymph nodesPresence of malignancyNoninvasive imaging studiesClinical evaluation toolCurative surgeryScan findingsBone scanLymph nodesTreatment optionsThorough history
1997
Positron Emission Tomography Measurement of Cerebral Metabolic Correlates of Tryptophan Depletion—Induced Depressive Relapse
Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS. Positron Emission Tomography Measurement of Cerebral Metabolic Correlates of Tryptophan Depletion—Induced Depressive Relapse. JAMA Psychiatry 1997, 54: 364-374. PMID: 9107153, DOI: 10.1001/archpsyc.1997.01830160092012.Peer-Reviewed Original ResearchConceptsCerebral metabolic correlatesDepressive relapseBrain metabolismMajor depressionMiddle frontal gyrusOrbitofrontal cortexTryptophan depletionMetabolic correlatesPositron emission tomography scanningFrontal gyrusRelapse-prone patientsPathogenesis of depressionPositron emission tomography (PET) measurementsSerotonin reuptake inhibitorsSymptoms of patientsPositron emission tomographySingle photon emissionSpecific brain regionsDorsolateral prefrontal cortexReuptake inhibitorsPlasma tryptophanLimbic regionsCaudate nucleusDepressive symptomsPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply